Can a Total Diabetes Drug Flip Sufferers’ Urine Into Alcohol?
One patient had just a few counterfeit obvious toxicology assessments after taking a favored diabetes drug.
In spite of now not ingesting alcohol for over 10 months, a person in his early 60s examined obvious for ethanol in his urine on the final four urine samples he supplied a probation pickle of business. No longer one of many urine samples contained any traces of illicit or non-prescribed substances.
Nonetheless after calling up his major care provider for apprehension of going to penal complex over the obvious assessments, the main care provider’s lab came across no detectable ethanol in a fresh urine sample, Aaron L. Schwartz, MD, PhD, of the Corporal Michael J. Crescenz Department of Veterans Affairs Clinical Heart in Philadelphia, detailed in a Contemporary England Journal of Treatment correspondence.
Even supposing they did now not discover ethanol on the repeat urine test, the main care lab did discover glycosuria fresh — an anticipated finding as the patient was once newly prescribed 20 mg day by day of the SGLT2 inhibitor empagliflozin (Jardiance) apt 5 months prior for his diabetes.
This led Schwartz to call up the metropolis probation pickle of business to ask about exactly how they hump about storing urine samples. In response, he was once informed that urine samples had been despatched once day by day to an external laboratory to be examined, however samples weren’t refrigerated sooner than transport.
To test a thought, the main care pickle of business took their fresh urine sample out of refrigeration. In the end later they retested the urine for ethanol after it remained at room temperature for 24 hours. Now, the sample examined obvious for ethanol.
“It seems this medication ended in my patient to like obvious urine assessments for alcohol even supposing he wasn’t ingesting alcohol,” Schwartz informed MedPage On the present time. “This seems to like came about for the reason that medication will increase the amount of sugar and bacteria within the urine. Microbes can flip sugar into alcohol within the linked methodology that grape juice turns into wine.”
“After I prescribed this medication for my patient’s diabetes, I never thought it could trigger this hurt,” he talked about.
He outlined how the SGLT2 inhibitor class of brokers produces glycosuria even when blood glucose ranges are within the now not fresh vary and likewise will increase the presence of microbes within the urinary tract — two factors wished for microbial fermentation.
After the obvious ethanol assessments on the metropolis probation center, the urine sample gathered by the main care facility 3 days later had a glucose stage of 1,000 mg/dL. It was once detrimental for urinary ethanol, urinary ethyl glucuronide, leukocyte esterase, nitrites, ketones, blood, and bilirubin. A urine culture confirmed decrease than 50,000 CFU/mL of blended gram-obvious organisms.
“On this case, the series and storage of urine samples by the criminal justice machine seems to were insufficient for guaranteeing specimen balance,” Schwartz infamous.
“I am hoping there would possibly per chance be the next consciousness of this imaginable phenomenon among clinicians,” he persisted. “Toxicology attempting out for illicit medicines and alcohol would possibly per chance be high stakes for sufferers, each within the criminal justice machine and the medical machine.”
He added that for the reason that class of SGLT2 inhibitors — which involves others esteem dapagliflozin (Farxiga), canagliflozin (Invokana), and ertugliflozin (Steglatro) — are typically prescribed for a huge-vary of diabetes, kidney, and cardiovascular indications, this would favor the functionality to like an worth on tons of sufferers.
“I would abet clinicians to keep in mind of whether or now not a patient is field to urine toxicology attempting out when taking this medication,” Schwartz urged. “A clinician ought to be severely skeptical of obvious assessments in these eventualities.”
-
Kristen Monaco is a senior workers author, specializing in endocrinology, psychiatry, and nephrology recordsdata. Primarily based out of the Contemporary York City pickle of business, she’s worked on the corporate since 2015.
Disclosures
Schwartz reported relationships with Aetna, the Lauren and John Arnold Foundation, Lown Institute, Medicare Price Advisory Commission, Tufts Clinical Heart, U.S. Company for International Building, VBID Health, and the Veterans Health Administration.
Major Provide
Contemporary England Journal of Treatment
Provide Reference: Schwartz AL “SGLT2 inhibitors and counterfeit obvious toxicology assessments” N Engl J Med 2024; DOI: 10.1056/NEJMc2313463.